A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.
AMA J Ethics. 2021;23(9):E712-720. doi:
10.1001/amajethics.2021.712.
Wendy E. Parmet, JD and Claudia E. Haupt, PhD, JSD
Clinicians using governing authority to make public health policy are ethically obliged to draw upon scientific and clinical information that accords professional standards.
AMA J Ethics. 2023;25(3):E194-199. doi:
10.1001/amajethics.2023.194.
Isabelle Freiling, PhD, Nicole M. Krause, MA, and Dietram A. Scheufele, PhD
Misinformation is an urgent new problem, so health professions communities need solutions as much as they need to be wary of ethical pitfalls of rushed interventions.
AMA J Ethics. 2023;25(3):E228-237. doi:
10.1001/amajethics.2023.228.
Clinicians in Catholic health care institutions cannot prescribe contraceptives for pregnancy prevention under a false diagnosis without committing fraud and contravening doctrine. Referrals are one option the authors consider for navigating patient requests for contraception.
AMA J Ethics. 2018;20(7):E630-636. doi:
10.1001/amajethics.2018.630.
Educators discussing ethically challenging topics with students should try to cultivate open mindedness while illuminating potential negative consequences that their health practice beliefs—such as refusing to provide abortion care—can have for patients, particularly those with limited options.
AMA J Ethics. 2018;20(7):E637-642. doi:
10.1001/amajethics.2018.637.
The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions.
Global health training offered through UCSF’s EMPOWUR program prepares ob/gyn residents to work in under-resourced communities locally as well as globally.
AMA J Ethics. 2018;20(3):253-260. doi:
10.1001/journalofethics.2018.20.3.medu1-1803.